Interactions between physicians and the pharmaceutical industry generally and sales representatives specifically and their association with physicians' attitudes and …
F Fickweiler, W Fickweiler, E Urbach - BMJ open, 2017 - bmjopen.bmj.com
Objectives The objective of this review is to explore interactions between physicians and the
pharmaceutical industry including sales representatives and their impact on physicians' …
pharmaceutical industry including sales representatives and their impact on physicians' …
Trends and patterns of antidepressant use in children and adolescents from five western countries, 2005–2012
CJ Bachmann, L Aagaard, M Burcu, G Glaeske… - European …, 2016 - Elsevier
Following the FDA black box warning in 2004, substantial reductions in antidepressant
(ATD) use were observed within 2 years in children and adolescents in several countries …
(ATD) use were observed within 2 years in children and adolescents in several countries …
Trends in ADHD medication use in children and adolescents in five western countries, 2005–2012
CJ Bachmann, LP Wijlaars, LJ Kalverdijk… - European …, 2017 - Elsevier
Over the last two decades, the use of ADHD medication in US youth has markedly
increased. However, less is known about ADHD medication use among European children …
increased. However, less is known about ADHD medication use among European children …
Association between academic medical center pharmaceutical detailing policies and physician prescribing
Importance In an effort to regulate physician conflicts of interest, some US academic medical
centers (AMCs) enacted policies restricting pharmaceutical representative sales visits to …
centers (AMCs) enacted policies restricting pharmaceutical representative sales visits to …
[图书][B] Innovations in psychosocial interventions and their delivery: Leveraging cutting-edge science to improve the world's mental health
AE Kazdin - 2018 - books.google.com
Millions of children, adolescents, and adults worldwide experience significant mental health
problems, for which they receive no treatment whatsoever. Despite decades of world-class …
problems, for which they receive no treatment whatsoever. Despite decades of world-class …
Making medicines affordable: a national imperative
SJ Nass, G Madhavan, NR Augustine - 2018 - books.google.com
Thanks to remarkable advances in modern health care attributable to science, engineering,
and medicine, it is now possible to cure or manage illnesses that were long deemed …
and medicine, it is now possible to cure or manage illnesses that were long deemed …
Drug firms' payments and physicians' prescribing behavior in Medicare Part D
In a pervasive but controversial practice, drug firms frequently make monetary or in-kind
payments to physicians in the course of promoting prescription drugs. We use a federal …
payments to physicians in the course of promoting prescription drugs. We use a federal …
[HTML][HTML] Key features of academic detailing: development of an expert consensus using the Delphi method
JS Yeh, TJ Van Hoof, MA Fischer - American health & drug benefits, 2016 - ncbi.nlm.nih.gov
Background Academic detailing is an outreach education technique that combines the direct
social marketing traditionally used by pharmaceutical representatives with unbiased content …
social marketing traditionally used by pharmaceutical representatives with unbiased content …
Gifts and influence: Conflict of interest policies and prescribing of psychotropic medications in the United States
M King, PS Bearman - Social Science & Medicine, 2017 - Elsevier
The pharmaceutical industry spends roughly 15 billion dollars annually on detailing–
providing gifts, information, samples, trips, honoraria and other inducements–to physicians …
providing gifts, information, samples, trips, honoraria and other inducements–to physicians …
Improving the affordability of prescription medications for people with chronic respiratory disease. An official American Thoracic Society policy statement
Background: Mounting evidence indicates that out-of-pocket costs for prescription
medications, particularly among low-and middle-income patients with chronic diseases, are …
medications, particularly among low-and middle-income patients with chronic diseases, are …